Determining the Prevalence of Secondary Aspergillus Infections in Influenza positive patients.

The Centers for Disease Control and Prevention intends to award a sole source firm fixed price purchase order to Facente Consulting, LLC. The title of the project is, “Determining the Prevalence of Secondary Aspergillus Infections in Influenza positive patients”. The vendor shall provide two-year retroactive laboratory and clinical data from suspected or confirmed influenza positive patients. This contract action is for (supplies/services) in which the Government intends to solicit and negotiate with only one source under the authority of FAR 13.106-1(b) (SAP) and 41 U.S.C. 3304(a)(1). Interested persons may identify their interest and capability to respond to the requirement. This notice of intent is not a request for competitive quotations; however, all responses received within fifteen (15) days of the issuance of this notice will be reviewed. A determination by the government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the government. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement. Any response should be emailed to the contract specialist at [email protected] by 10:00am EST Tuesday, July 21st, 2020.